Chemical structure of Dolutegravir-d3
Catalogue No.
CSL-185555
CAS No.
Not assigned
Molecular formula
C20H16D3F2N3O5
Molecular weight
422.40
Parent drug
Dolutegravir
Product type
Pharmaceutical Reference Standards, Intermediates and building blocks, pharmaceutical standards, Fine Chemicals
Quick quote · CSL-185555Price and availability on request
ISO 17034:2016 · GLP

Tell us the quantity you need, from a few milligrams upwards, and we reply within 24 hours with price, availability and delivery time.

Need documents or a larger lot? Use the full quote form

Synonyms

  • (4R,12aS)-N-((2,4-Difluorophenyl-3-d)methyl-d2)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
  • Isotope labelled Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.

More Dolutegravir products

All 128 →